AMGN CHMP opinion: Thursday, September 17, 2026

Variation type II · LUMYKRAS · Update of section 4.8 of the SmPC in order to delete four renal toxicity adverse drug reactions (ADRs) based on review of safety data; the Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to update the list of local representatives in t

Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.